about
Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkStainable hepatic iron in 341 African American adults at coroner/medical examiner autopsyGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseMolecular mediators of hepatic steatosis and liver injuryEthnic differences in the link between insulin resistance and elevated ALT.The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome.Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?Inflammation in nonalcoholic steatohepatitis.Gender and racial differences in nonalcoholic fatty liver disease.Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES IIINonalcoholic Fatty liver disease and obesity.Genome-wide analysis of hepatic lipid content in extreme obesityEthnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.Ethnicity and nonalcoholic fatty liver diseaseAre there ethnicity-based differences in the evaluation of individuals with abnormal liver biochemistries?Nonalcoholic fatty liver disease: a review.Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority PopulationsRacial differences in nonalcoholic fatty liver disease in the U.S. populationRisk factors and mechanisms of non-alcoholic steatohepatitisNonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?Racial disparity in liver disease: Biological, cultural, or socioeconomic factors.Ethnic differences in hepatic steatosis: an insulin resistance paradox?Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis.Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression.Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors.Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).Ethnic differences in the prevalence of cryptogenic cirrhosis.Age- and ethnic-specific elevation of ALT among obese children at risk for nonalcoholic steatohepatitis (NASH): implications for screening.Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?Treatment options for nonalcoholic fatty liver disease.Nonalcoholic Fatty Liver Disease in Severely Obese Subjects
P2860
Q24631619-BD7040FB-4A1C-4E31-9756-BA6E24BC720EQ24795077-0ECB1CE0-64BC-48E8-8A74-AAFC26808E62Q29614897-65657811-5E9B-46F1-B71B-62974CA0DE5CQ29616709-2FEA6A39-3D54-46D2-BE46-FE74081893A7Q30411106-4C22498C-6440-443D-90CF-A36DEF179308Q30431218-51524F40-49B6-46F1-B382-B4DFE239C1BDQ30443852-576CEBA6-288C-4002-80AF-56AF77DFD67BQ30453231-A7AB8037-5280-4BE3-88C6-1E8DFE88AE20Q33660001-98020DE9-C36B-4F00-B225-D1676764C561Q34223422-CE904363-71D1-4F54-8BDF-3FEDEFB3F670Q34605022-0939C57A-ADE5-43EB-BB9E-B7FC72734BC5Q35209121-D9650895-08B9-43C6-8C6B-66D142B26EC5Q35538949-20AE3530-EB90-4E50-9EED-7D46D7535C3DQ35600786-DE01E281-FEAD-45C2-B45A-CB2181CAEE5FQ35754063-59AF96D7-4304-48D9-8390-840642111107Q35914567-796575D3-501E-403B-A8CE-1E919F3708F1Q36219675-C2B95DDF-D6C2-43D5-9275-B7BAEE958FD5Q36619701-93BE49DC-B4EF-423E-B72A-89BC0788BA56Q36818424-D3C14CB6-6BAD-4924-A077-D38FC6424EEEQ36948248-03D37FB2-4EE4-4772-9729-942C63D7D9CCQ37009739-7A752B6A-EF80-4B63-B229-1D058A3D4163Q37077557-C2B15D37-371D-4861-AC0A-2EE25DADCEB7Q37095472-FA0F8F72-B892-4755-9D1F-003E401334F4Q37175282-7E5AC45B-7AB1-4D2E-B366-C4A52CF900FCQ37585296-94421EB2-FDDD-4650-AE8E-E7F2721FA849Q37678998-3E022CA0-5D4E-4CDB-A5BD-60345CB5EA9BQ37699734-DBA8DFAC-CDD5-4CF5-BB0E-E4EB30B1C579Q38000540-25E0D598-0D92-4FA2-B1CC-8D2F9A2C2B9CQ38360416-8ED9AB28-8321-4729-B72A-D9F9CF098B45Q42948188-1FE58FA7-FFBA-4335-8913-9CA58173A118Q43432147-C1B6DE69-7C8B-4FCC-88FE-2C71BD12EC45Q46012959-9FA6ECEB-1C2C-461A-BFCC-D4459306F963Q46186734-AD5CA4F0-14B3-4BCD-BE9B-0C5A4C9E0D50Q46219060-8A2F394D-B390-4B90-A808-2B8045F84F24Q47880294-F91B82EC-92D9-44D7-B909-DF9AC1B4F199Q53293047-754A3AEA-3617-45D5-9592-33CF33D8C754Q55460608-4B81AA3F-B23A-48EC-B786-FD68C6DE9C44Q58816508-371FDB7C-F1D8-43E4-887C-6630C38FB304
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Is NASH underdiagnosed among African Americans?
@ast
Is NASH underdiagnosed among African Americans?
@en
type
label
Is NASH underdiagnosed among African Americans?
@ast
Is NASH underdiagnosed among African Americans?
@en
prefLabel
Is NASH underdiagnosed among African Americans?
@ast
Is NASH underdiagnosed among African Americans?
@en
P2093
P2860
P1476
Is NASH underdiagnosed among African Americans?
@en
P2093
Danielle M Harris
Elizabeth E Hespenheide
James T Patrie
Stephen H Caldwell
P2860
P304
P356
10.1111/J.1572-0241.2002.05795.X
P407
P577
2002-06-01T00:00:00Z